US FDA to enhance warnings on antidepressant labelling

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1020, 2004-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The US FDA has informed healthcare professionals that Baxter has revised the Warnings section of the labelling for heparin sodium injection

Reactions Weekly, Vol. 1, Iss. 1132, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The US FDA has informed healthcare professionals that Baxter has revised the Warnings section of the labelling for heparin sodium injection

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

US FDA revises labelling for PPIs

Reactions Weekly, Vol. 1, Iss. 1304, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

US NovoSeven labelling update includes new AEs and warnings

Reactions Weekly, Vol. 1, Iss. 1081, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

GSK agrees with FDA: new US labelling for Advair and Serevent

Reactions Weekly, Vol. 1, Iss. 1093, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite